规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | JR14a, a potent thiophene antagonist of the human complement C3a receptor, exhibits selectivity for the human C3a receptor over the C5a receptor and can mitigate C3aR-mediated inflammation [1]. |
体内研究 | JR14a (10 mg/kg; pO. 2 h prior) diminishes paw swelling by 65% compared to control 30 minutes after agonist injection in an acute rat paw model of inflammation and edema [1]. JR14a (1 mg/kg; i.v.) exhibits an elimination half-life of 191 minutes, a clearance of 4.4 mL/min/kg, and an AUC of 3795 ng h/mL in rats [1]. JR14a (10 mg/kg; pO.) in rats displays a Cmax of 88 ng/mL, Tmax of 300 minutes, and an AUC of 478 ng h/mL [1]. |
体外研究 | JR14a (0.1 nM-100 μM) blocks C3a-induced intracellular Ca2+ release in human monocyte-derived macrophages, exhibiting an IC50 of 10 nM [1]. JR14a (0.1 nM-100 μM) maintains metabolic stability after exposure to rat liver microsomes for 1 hour [1]. JR14a (0.1 nM-100 μM) hinders C3a-induced β-hexosaminidase secretion in human LAD2 mast cells, with an IC50 of 8 nM [1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.87mL 0.37mL 0.19mL |
9.37mL 1.87mL 0.94mL |
18.75mL 3.75mL 1.87mL |
CAS号 | 2411440-41-8 |
分子式 | C25H26Cl2N4O3S |
分子量 | 533.47 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(196.82 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |